Related Experiment Videos
1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide
1Department of Cardiology, Northern General Hospital, Sheffield, UK.
International Journal of Cardiology
|April 1, 1993
Summary
This study shows that combining digoxin and flecainide for paroxysmal atrial flutter can slow the heart rate but may lead to 1:1 atrioventricular conduction. Careful monitoring is essential during treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrial flutter is a common supraventricular tachycardia.
- Effective rate and rhythm control is crucial for patient outcomes.
Observation:
- A 65-year-old male patient presented with paroxysmal atrial flutter.
- Treatment involved a combination of digoxin and flecainide.
Findings:
- The combination therapy successfully slowed the atrial flutter rate to 190 beats per minute.
- However, intermittent 1:1 atrioventricular conduction was observed, posing a risk.
Implications:
- Dual therapy requires vigilant monitoring for potential adverse events like 1:1 AV conduction.
- Further research may explore optimized dosing or alternative strategies for managing atrial flutter.